Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
8 min read
ABHD5 Target Evaluation Report 2026: Biology, Validation, Competition, IP, and R&D Strategy
23 July 2026
A visual target evaluation report for ABHD5, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
8 min read
ABHD4 Target Evaluation Report 2026: Biology, Validation, Competition, IP, and R&D Strategy
23 July 2026
A visual target evaluation report for ABHD4, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
8 min read
ABHD3 Target Evaluation Report 2026: Biology, Validation, Competition, IP, and R&D Strategy
23 July 2026
A visual target evaluation report for ABHD3, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
Latest Hotspot
8 min read
Fucosidosis Indication Strategy Report 2026: FUCA1, Trials and Deals
23 July 2026
2026 Fucosidosis strategy: epidemiology, FUCA1 biology, clinical competition, recent deals, unmet need and market attractiveness. Evidence synthesized with…
8 min read
ABHD2 Target Evaluation Report 2026: Biology, Validation, Competition, IP, and R&D Strategy
23 July 2026
A visual target evaluation report for ABHD2, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
8 min read
ABHD1 Target Evaluation Report 2026: Biology, Validation, Competition, IP, and R&D Strategy
23 July 2026
A visual target evaluation report for ABHD1, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
8 min read
ABCG8 Target Evaluation Report 2026: Biology, Validation, Competition, IP, and R&D Strategy
23 July 2026
A visual target evaluation report for ABCG8, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
8 min read
ABCG5 Target Evaluation Report 2026: Biology, Validation, Competition, IP, and R&D Strategy
23 July 2026
A visual target evaluation report for ABCG5, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
8 min read
ABCG4 Target Evaluation Report 2026: Biology, Validation, Competition, IP, and R&D Strategy
23 July 2026
A visual target evaluation report for ABCG4, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
8 min read
ABCG1 Target Evaluation Report 2026: Biology, Validation, Competition, IP, and R&D Strategy
23 July 2026
A visual target evaluation report for ABCG1, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
Latest Hotspot
8 min read
Beta-mannosidosis Indication Strategy Report 2026: MANBA, Trials and Deals
23 July 2026
2026 Beta-mannosidosis strategy: epidemiology, MANBA biology, clinical competition, recent deals, unmet need and market attractiveness. Evidence synthesized with…
8 min read
ABCF3 Target Evaluation Report 2026: Biology, Validation, Competition, IP, and R&D Strategy
23 July 2026
A visual target evaluation report for ABCF3, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.